Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYS1 golgi trafficking protein is an integral membrane protein involved in vesicular trafficking within the cell, particularly associated with the Golgi apparatus[1][5]. SYS1 forms a complex with ARFRP1 (ADP-ribosylation factor-related protein 1) and is responsible for targeting ARFRP1 to the Golgi membrane, which is essential for normal protein sorting and trafficking[1][5]. It is predicted to play a role in transporting proteins from the Golgi to endosomes and the plasma membrane, and ensuring proper protein localization in the Golgi[2]. While associated with certain diseases such as familial hypertrophic cardiomyopathy type 13, there is currently no evidence supporting SYS1 as a direct therapeutic target or its involvement in drug interactions[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SYS1 golgi trafficking protein (SYS1).